NCT00658905已完成2 期
A Prospective, Randomized, Double-blind Crossover Study Comparing 0.15 g/L rhBSSL Added to Infant Formula Versus Placebo During One Week of Treatment in Preterm Infants Born Before Week 32 of Gestational Age
Swedish Orphan Biovitrum6 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2008年4月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 33
- 试验地点
- 6
- 主要终点
- Coefficient of Fat Absorption in stool
研究概览
简要总结
The purpose of this study is to evaluate the efficacy in preterm infants following treatment with BSSL when administered in infant formula.
详细描述
In this double-blind crossover study, patients will be randomized to receive infant formula including BSSL or infant formula without BSSL for the first 7 days. After a wash-out period of 2 days the patients will "crossover" to the other treatment regimen and receive an additional 7 days treatment. The primary efficacy measurements will be made by collecting stool during the last three days of each treatment period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- — 至 32 Weeks（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Preterm infants
- •less than or equal to 32 weeks of gestational age
- •appropriate for gestational age
- •enterally fed with infant formula
排除标准
- 未提供
研究组 & 干预措施
rhBSSL
Active Comparator
干预措施: rhBSSL (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
Coefficient of Fat Absorption in stool
时间窗: Stool collected for a 72-hour period during the final 3 days of each treatment period
次要结局
- Change in length and body weight between the start and end of each treatment period(Baseline and after one week of treatment)
研究者
研究点 (6)
Loading locations...
相似试验
已完成
2 期
Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Pasteurized Breast Milk for Preterm InfantsReplacement Therapy in Preterm InfantsNCT00659243Swedish Orphan Biovitrum32
终止
2 期
Blepharospasm Short IntervalBlepharospasmNCT00507637Merz Pharmaceuticals GmbH8
已完成
2 期
Mid and Standard Frequency Ventilation in Infants With Respiratory Distress SyndromeVentilator-Induced Lung InjuryRespiratory Distress SyndromePreterm InfantBronchopulmonary DysplasiaNCT03231735University of Alabama at Birmingham60
已完成
不适用
A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic DermatitisHealthyNCT04662619Johnson & Johnson Consumer Inc. (J&JCI)273
已完成
4 期
Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline ContourContourNCT03425253Allergan58